BRD2 and polycystic ovary syndrome: Patients with polycystic ovary syndrome(PCOS) are at high risk for iatrogenic ovarian hyperstimulation, and the FSH/LH ratio is usually decreased in PCOS and elevated in subjects with pituitary tumours, so attention should be paid to the diagnosis of these diseases.